FDA Advisers Would End Asthma Indications for Two Long-Acting Be...

Courtesy MedPage Today Allergy & Immunology  Thu, 12/11/2008 - 15:06

ROCKVILLE, Md. (MedPage Today) -- Advisers to the FDA voted today to recommend to the agency that two single-agent long-acting beta2 agonist inhalers be stripped of their asthma indications.


 

More related items

FDA Advisers Consider Safety of Long-Acting Beta...
ROCKVILLE, Md. (MedPage Today) -- A panel of FDA advisers reviewing the safety of long-acting beta agonist inhalers heard calls today from two agency staffers to ban the use of the drugs in...

Traffic-Related Asthma Costs Underestimated (CME/CE)
(MedPage Today) -- The impact that motor vehicle exhaust has on asthma costs is much bigger than once thought, researchers warned.

Early Infant Weight Gain Tied to Asthma (CME/CE)
(MedPage Today) -- Rapid weight gain during the first months of life is associated with an increased risk of asthma, a prospective Dutch cohort study suggested.

Finger Pulse Oximeter Octive Tech 300C with Hard...
OctiveTech 300C Digital Finger Pulse Oximeter combines advanced technology with a stylish, wearable design. The outstanding interference resistance capacity against ambient light along with...

Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
Baby Bee Buttermilk Lotion contains only Mother Nature's safe and gentle ingredients, and is enriched with vitamin E, Aloe Vera and Buttermilk to provide soothing and nourishing emollients...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com